1,390
Views
47
CrossRef citations to date
0
Altmetric
Research Paper

MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells

, &
Pages 792-800 | Received 24 Mar 2017, Accepted 24 Aug 2017, Published online: 13 Oct 2017

References

  • Lee KT, Tan JK, Lam AK, Gan SY. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review. Crit Rev Oncol Hematol. 2016;103:1-9. doi:10.1016/j.critrevonc.2016.04.006. PMID:27179594
  • Chan KC, Chan LS, Ip JCY, Lo C, Yip TTC, Ngan RKC, Wong RNS, Lo KW, Ng WT, Lee AWM. Therapeutic targeting of CBP/[bgr]-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin. Sci Rep. 2015;5:9979. doi:10.1038/srep09979.
  • Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM. Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Head Neck. 2008;30:946-63. doi:10.1002/hed.20833. PMID:18446839
  • Vikram R, Ramachandran R, Abdul KSM. Functional significance of long non-coding RNAs in breast cancer. Breast Cancer. 2014;21:515-21. doi:10.1007/s12282-014-0554-y. PMID:25038622
  • Zhang F, Zhang L, Zhang C. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies. Tumor Biol. 2016;37:163-75. doi:10.1007/s13277-015-4445-4.
  • Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839:1097-109. doi:10.1016/j.bbagrm.2014.08.012. PMID:25159663
  • Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y. TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res. 2014;20:1531-41. doi:10.1158/1078-0432.CCR-13-1455. PMID:24449823
  • Huang N, Chi Y, Xue J, Liu M, Huang S, Mo M, Zhou S, Wu J. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer. Oncotarget. 2016; 7:37957-65. doi:10.18632/oncotarget.9364. PMID:27191888
  • Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Inoue Y, Mohri Y, Kusunoki M, Boland CR, Goel A. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis. 2014; 35:2731-9. doi:10.1093/carcin/bgu200. PMID:25280565
  • Jin C, Yan B, Lu Q, Lin Y, Ma L. The role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal carcinoma. Tumor Biol. 2016;37:4025-33. doi:10.1007/s13277-015-4227-z.
  • Xia J, Wu Z, Yu C, He W, Zheng H, He Y, Jian W, Chen L, Zhang L, Li W. miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1. J Pathol. 2012;227:470-80. doi:10.1002/path.4030. PMID:22450659
  • Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2010; 31:766-76. doi:10.1093/carcin/bgp250. PMID:19843643
  • Peng XH, Huang HR, Lu J, Liu X, Zhao FP, Zhang B, Lin SX, Wang L, Chen HH, Xu X. MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma. Mol Cancer. 2014;13:1. doi:10.1186/1476-4598-13-186. PMID:24387052
  • Xu S, Zhao N, Hui L, Song M, Miao ZW, Jiang XJ. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3. Oncol Rep. 2016;35:1385-94. doi:10.3892/or.2015.4524doi:10.3892/or.2015.4524. PMID:26707908
  • Lluri G, Langlois GD, Soloway PD, Jaworski DM. Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and β1 integrin expression in vitro. Exp Cell Res. 2008;314:11-24. doi:10.1016/j.yexcr.2007.06.007. PMID:17678891
  • Gutschner T, Hämmerle M, Diederichs S. MALAT1-a paradigm for long noncoding RNA function in cancer. J Mol Med. 2013;91:791-801. doi:10.1007/s00109-013-1028-y. PMID:23529762
  • Liu S, Song L, Zeng S, Zhang L. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells. Tumor Biol. 2016;37:633-40. doi:10.1007/s13277-015-3732-4.
  • Yang MH, Hu ZY, Xu C, Xie LY, Wang XY, Chen SY, Li ZG. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta. 2015;1852:166-74. doi:10.1016/j.bbadis.2014.11.013. PMID:25446987
  • Shen L, Chen L, Wang Y, Jiang X, Xia H, Zhuang Z. Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer. J Neurooncol. 2015;121:101-8. doi:10.1007/s11060-014-1613-0. PMID:25217850
  • Hua WF, Zhong Q, Xia TL, Chen Q, Zhang MY, Zhou AJ, Tu ZW, Qu C, Li MZ, Xia YF. RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma. Cell Death Dis. 2016;7:e2352. doi:10.1038/cddis.2016.252. PMID:27584791
  • Yoon JH, Abdelmohsen K, Gorospe M: Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol. 2014;34:9-14. doi:10.1016/j.semcdb.2014.05.015. PMID:24965208
  • Li Q, Zhang C, Chen R, Xiong H, Qiu F, Liu S, Zhang M, Wang F, Wang Y, Zhou X. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma. Cancer Lett. 2016;383:28-40. doi:10.1016/j.canlet.2016.09.019. PMID:27693631
  • Luan W, Li L, Shi Y, Bu X, Xia Y, Wang J, Djangmah HS, Liu X, You Y, Xu B. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22. Oncotarget. 2016;7: 63901-12. doi:10.18632/oncotarget.11564. PMID:27564100
  • Wang S, Zhang W, Wu X, Zhang M, Weng M, Zhou D, Wang J, Quan Z. Long non-coding RNA Malat1 promotes gallbladder cancer development by acting as a molecular sponge to regulate miR-206. Oncotarget. 2016; ;7:37857-67. doi:10.18632/oncotarget.9347. PMID:27191262
  • Hanna RA, Campbell RL, Davies PL. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature. 2008;456:409-12. doi:10.1038/nature07451. PMID:19020623
  • Storr SJ, Carragher NO, Frame MC, Parr T, Martin SG. The calpain system and cancer. Nat Rev Cancer. 2011;11:364-74. doi:10.1038/nrc3050. PMID:21508973
  • Cai JJ, Qi ZX, Chen LC, Yao Y, Gong Y, Mao Y. miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4. Oncol Rep. 2016; 35: 284-90. doi:10.3892/or.2015.4355. PMID:26530859
  • Gu J, Xu FK, Zhao GY, Lu CL, Lin ZW, Ding JY, Ge D. Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2. Med oncol. 2015;32:1-8. doi:10.1007/s12032-015-0500-7.
  • Zheng PC, Chen X, Zhu HW, Zheng W, Mao LH, Lin C, Liu JN, Zheng M. Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expression. Cancer sci. 2014;105:630-8. doi:10.1111/cas.12416. PMID:24703594
  • Xiao H, Tang K, Liu P, Chen K, Hu J, Zeng J, Xiao W, Yu G, Yao W, Zhou H. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma. Oncotarget. 2015;6:38005. doi:10.18632/oncotarget.5357. PMID:26461224

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.